论医疗产品损害责任的举证责任分配——以“输血感染丙肝案”为例

On the Allocation of Burden of Proof of Liability for Medical Product Damage——Taking the "Case of Hepatitis C Infected by Blood Transfusion" as an Example

《侵权责任法》第五十九条将药品、消毒产品、医疗器械和血液界定为医疗产品,但该法未明确对于医疗产品损害责任的举证责任。本文结合我国法律法规的规定分析一起疑似输血感染丙肝案,得出结论:医疗产品损害责任的举证责任分配不应单纯地分配给原、被告中的一方,而应从公平的角度让原、被告分担。

In article 59 of Tort Liability Law,drugs, disinfectant products, medical devices and blood are classified as medical products, but the burden of proof for the liability of medical product damage is not specified in it. Through the analysis on one case of hepatitis C infected by blood transfusioin, combined with laws and regulations in China, the following conclusion can be drew： the burden of proof of liability for medical product damage should not simply be assigned to the plaintiff or defendant, and should let them share the liability from the perspective of fairness.